Jianchun Duan

Assessment of Blood Tumor Mutational Burden as a Potential Biomarker for Immunotherapy in Patients With Non–Small Cell Lung Cancer With Use of a Next-Generation Sequencing Cancer Gene Panel

Zhijie Wang, Jianchun Duan, Shangli Cai et al. · JAMA Oncology · 2019 · 495 citations · Full text

Medicine, Molecular Genetics, Oncology +17

AENEAS: A Randomized Phase III Trial of Aumolertinib Versus Gefitinib as First-Line Therapy for Locally Advanced or MetastaticNon–Small-Cell Lung Cancer With <i>EGFR</i> Exon 19 Deletion or L858R Mutations

Shun Lü, Xiaorong Dong, Hong Jian et al. · Journal of Clinical Oncology · 2022 · 279 citations · Full text

Medicine, Oncology, Pharmacology +16

Comutations in DNA Damage Response Pathways Serve as Potential Biomarkers for Immune Checkpoint Blockade

Zhijie Wang, Jing Zhao, Guoqiang Wang et al. · Cancer Research · 2018 · 261 citations

Life Sciences, Immunology, Oncology +17

Multiregion Sequencing Reveals the Genetic Heterogeneity and Evolutionary History of Osteosarcoma and Matched Pulmonary Metastases

Di Wang, Xiaohui Niu, Zhijie Wang et al. · Cancer Research · 2018 · 160 citations

Medicine, Genetics, Oncology +17

Single-cell transcriptomic profiling reveals the tumor heterogeneity of small-cell lung cancer

Yanhua Tian, Qingqing Li, Zhenlin Yang et al. · Signal Transduction and Targeted Therapy · 2022 · 148 citations · Full text

Medicine, Cancer Biology, Oncology +15